Whether exploring a promising new therapy, developing a pioneering technology, or just helping people live longer healthier lives, scientific research is an essential part of our success as a company.

This course will look at the different types of research we support and will explain how laws and regulations, along with our own internal policies and procedures, have been put in place to protect the integrity of this research. It will also provide you with some practical advice on how to ensure that we continue doing research not only in the right way, but also for the right reasons.

Upon completion of this course, you will be able to:

• Explain why Abbott conducts and supports scientific research;
• Distinguish between the different types of research Abbott conducts and supports;
• Explain the reasons for some of the key laws, regulations, and standards that govern scientific research;
• State the requirements that Abbott has put in place to govern the way in which we conduct research;
• Describe the roles and responsibilities of scientific personnel as opposed to sales, marketing, and other non-scientific personnel; and
• Know where to go for help and support.

The icons at the top of the screen provide one-click access to key resources:

• The Table of Contents,
• Important contact information, and
• Reference material.

In addition, you can use the Audio icon to turn the audio on or off and the Exit icon to close the course window.

There are several features to help guide you through the course:

• The Back and Forward arrows allow you to move from screen to screen.
• A horizontal slider bar at the bottom of the screen allows you to see where you are in the course.
• The Table of Contents lets you navigate from section to section.

Knowledge Check

Once you have reviewed the content of this course, you will be required to complete a 10-question Knowledge Check.

The Knowledge Check can be taken at any time by clicking the Table of Contents icon and selecting Knowledge Check.

Development of products that help people live longer and healthier lives is a long and complex process.

In this section, we will explain why we conduct research, and outline the different kinds and levels of scientific research we support.

Scientific research helps us determine if a product is effective.

In other words, it tells us if a product works. And if it does work, how well.

Scientific research provides us with the evidence that is required for regulatory approvals and market access decisions around the world.

It serves as the basis for promotional claims once a product is approved.

Scientific research helps us to gain knowledge about product safety both before and after we launch a product.

It helps to answer the question: is the product safer than what’s currently available on the market? And if so, for whom, how much, etc.?

Scientific research answers many other questions as well. In doing so, it helps us to produce products that are not only safe and effective, but also:

• Easier to use,
• More cost effective, and
• More reliable.

As we make our way through this course, you will learn more about the benefits of scientific research, and more importantly, about the role each of us has to play in safeguarding its integrity.

There are many different kinds and levels of scientific research that Abbott supports.

Generally, this research breaks down into two broad categories: company-sponsored trials and investigator-initiated trials.

Company-sponsored Trials are studies that are designed and managed by Abbott.

These studies typically include one or more participating medical centers (institutions), with properly qualified physicians or other healthcare professionals (investigators) administering the study.

Before a new product is approved for treatment or use, Abbott conducts a trial or series of trials to prove that the product is safe and effective, and to ultimately understand the extent of effectiveness.

These trials are often referred to as investigational or pre-marketing/pre-approval clinical trials (also sometimes referred to as Phase I, II, or III trials). They generally provide the evidence to support regulatory approvals required to market our products in jurisdictions around the world.

Once a product or treatment is approved, Abbott sometimes conducts additional research.

This research is commonly referred to as post-approval observational or post-marketing, or Phase IV trials. Its aim is to help us better understand longer-terms effects or performance of the product. These trials are sometimes even required as a condition of product approval.

What is most important to understand is that while there may be third-party institutions and investigators participating in the conduct of clinical trials, Abbott is responsible for company-sponsored trials.

Investigator-initiated Studies (IIS)/Investigator Sponsored Studies (ISS) are studies that are initiated, designed, and conducted by external investigators and institutions.

That is to say, the investigator or institutional sponsors are responsible for the conduct of such studies.

IIS/ISS studies can include, for example:

• Additional research into approved uses of marketed products,
• Comparisons with other therapies, and
• Investigations into potential new uses of existing products.

In some cases, Abbott may choose to provide funding and/or other support for Investigator-initiated or Sponsored Studies.

For example, the Company may provide Abbott product to be used in an IIS.

However, it is important to keep in mind that as we are not the study sponsor and are not responsible for conduct of the IIS/ISS, our involvement is generally limited:

• We do not initiate investigator-initiated studies.
• We are not responsible for design of the protocol.
• We do not conduct or supervise the research.
• We are not responsible for analyzing the data from the study.

Limiting our involvement in the conduct of IIS/ISS is necessary so there’s no misunderstanding around who is responsible for the study, and to help maintain the integrity and independence of the study results.

However, as we will see later, there are a number of things we need to do in order to ensure our compliance with the rules and regulations governing IIS/ISS.

We conduct research to help us produce products that are not only safe and effective, but also easier to use, more cost effective, and more reliable.

Company-sponsored trials

Company-sponsored Trials are studies that are designed and managed by Abbott. These studies include:

• Investigational or pre-marketing/pre-approval clinical trials (also sometimes referred to as Phase I, II, or III trials), which provide evidence to support regulatory approvals required to market our products in jurisdictions around the world; and
• Post-approval observational or post-marketing, or Phase IV trials, which aim is to help us better understand longer-terms effects or performance of the product.

Investigator-Initiated Studies (IIS)/Investigator-Sponsored Studies (ISS)

Investigator-initiated Studies (IIS)/Investigator Sponsored Studies (ISS) are studies that are initiated, designed, and conducted by external investigators and institutions. As Abbott is not the study sponsor, our involvement is generally limited:

• We do not initiate investigator-initiated studies.
• We are not responsible for design of the protocol.
• We do not conduct or supervise the research.
• We are not responsible for analyzing the data from the study.

Abbott is committed to ensuring objectivity in research, protecting research participants, and guaranteeing timely and transparent disclosure of study results.

In this section, we will look at what is being done to ensure that our research activities remain focused on the legitimate advancement of science and free from inappropriate commercial influence.

Government agencies and regulatory authorities around the world set out laws, regulations, and standards governing many aspects of the research process from clinical trial design to the selection of investigators, from research funding to the timely reporting of meaningful study results.

It is important to understand these requirements to ensure the research Abbott conducts aligns with all applicable laws, regulations, and standards.

In essence, the laws and regulations that govern scientific research can be broken down into two broad categories:

• Laws and regulations governing why we support research; and
• Laws and regulations governing how we conduct and support research.

The question of why we conduct or support research is of particular interest to regulators and government agencies.

Government agencies want to ensure that research funding is never used as a reward for buying, using, influencing the use of, or recommending our products, or as a means to promote an unapproved or off-label use of a product.

Activity: Scenario

Imagine . . .

You work in Research and Development. You set up a robust post-marketing trial for the purpose of comparing the long-term safety of Abbott’s drug-alluding stents with that of a competitor’s. You recruit a group of highly qualified vascular surgeons (some of whom currently use Abbott stents and some who use a competitor’s technology) solely on the basis of their qualifications and expertise, and pay them fair market value compensation for their services.

That's not correct!

That's correct!

That's partially correct!

Activity: Questions

Is there anything in this arrangement that you think might raise a red flag with government regulators?

[1] Yes.

[2] No.

Submit

Activity: Feedback

• The trial design is robust;
• The endpoint (comparing the long-term safety of Abbott’s stents with that of a competitor’s) is clear;
• The selection of investigators has been properly based on qualifications and expertise; and
• Payment is based on fair market value compensation.

Activity: Scenario

Now imagine . . .

You set up exactly the same trial: same endpoint, same group of doctors, same compensation. The only difference is that this time the trial is being driven by the Xience marketing group, who see it as a great opportunity to introduce their stents to a new group of doctors.

That's not correct!

That's correct!

That's partially correct!

Activity: Questions

Do you think government regulators would still view this clinical trial as okay?

[1] Yes.

[2] No.

Submit

Activity: Feedback

Even though on the surface it's the same exact trial – same endpoint, same group of doctors, same compensation – something fundamental has changed.

What's changed is the reason why the research is being conducted. It is now clear that the real intent of the study isn’t to test the long-term safety of two technologies side-by-side, but rather to familiarize some of the vascular surgeons with Abbott’s stents.

Studies like this, where the intended objective is to introduce a new product or therapy to physicians, spur sales of the product, or reward physicians for using a product – rather than test a scientific hypothesis or collect data to fill a legitimate need – are often called “seeding” or “marketing” trials.

Seeding trials could be considered illegal, if the payment is intended to reward or induce investigators to use or recommend a particular product.

In fact, any trial that is used for the purpose of improperly inducing or rewarding someone to use or recommend a company’s products, or to improve access to, or relationships with, health care professionals (HCPs) or investigators, may be considered illegal based on anti-corruption or anti-kickback laws.

CLICK THE OTHER LAWS BUTTON TO LEARN MORE.

OTHER LAWS

Other laws that target kickbacks and corrupt and fraudulent practices in the clinical research context, include:

• The U.S. Anti-kickback Statute
• The Foreign Corrupt Practices Act
• The U.K. Bribery Act
• The Prevention of Corruption Law in India
• The Countermeasures Against Corruption Law in Russia

The bottom line is that it is illegal to make research payments or provide other items of value in order to improperly induce or reward investigators and HCPs to use or recommend the company’s products.

It is also illegal to conduct scientific research as a “disguised” means of promoting unapproved uses of Abbott products.

For example, supporting a research study that has little or no scientific value in order to get a product used in an unapproved manner would likely be viewed as off-label promotion of the product – which is prohibited by Abbott policies and is illegal in many jurisdictions.

The question of how we conduct or support research is also of interest to regulatory authorities.

In most trials, government agencies and regulatory authorities specify requirements for nearly every aspect of the research process.

CLICK THE RESEARCH REQUIREMENTS BUTTON TO LEARN MORE.

RESEARCH REQUIREMENTS

Authorities specify requirements relating to:

• The design of the clinical trial;
• The selection and funding of investigators and study sites;
• The monitoring of the trial;
• The reporting of serious adverse events and safety issues;
• Patient authorization and informed consent;
• Patient privacy; and
• The reporting of study results.

In addition, voluntary standards, such as Good Clinical Practice (GCP) and Good Scientific Practice (GSP), set out further guidelines designed.

These guidelines help to ensure both the integrity of the scientific method, as well as patient safety and consent. There are even guidelines, such as the International Committee of Medical Journal Editors (ICMJE), that set out criteria for who can and should be named as authors on scientific research publications.

Let’s now take a look at some of the internal requirements that help ensure we comply with these laws, regulations, and standards.

First and foremost, Abbott ensures that all research fills a legitimate need.

That means that before any research begins, Abbott reviews the research proposal to confirm it:

• Follows appropriate clinical or scientific practices,
• Has a clear hypothesis or end point, and
• Has the legitimate goal of advancing clinical or scientific understanding.

Once approved, Abbott selects investigators and sites based on relevant criteria, such as:

• Training and experience;
• Access to relevant patient or consumer populations;
• Appropriate research facilities; and
• History of conducting research in accordance with all applicable legal, regulatory, and other requirements.

Abbott never bases its selection decisions on marketing objectives, such as the desire to gain or improve access to particular customers or to reward customers for the value or volume of their business.

Abbott also has requirements to ensure that investigators and sites selected to conduct research are not debarred, restricted, or otherwise disqualified from conducting research by any relevant regulatory authority or governing body.

Compensation paid to investigators or sites is always reasonable and based on fair market value for the country where the research is conducted.

Compensation and other terms reflective of materials, overhead and any other support provided is documented in a contract with the investigator or site conducting the research. And, under no circumstances is compensation ever to be tied to the outcome of the study.

Once the study results are available, Abbott requires timely reporting in an objective, accurate, and complete manner.

CLICK EACH OF THE PANELS TO LEARN MORE.

Company-sponsored Trials

In the case of company-sponsored trials where Abbott has control and full responsibility for the study and is required to register and post results, Abbott ensures that these studies are registered, and meaningful study results are shared through scientific posters, medical journals, and publicly accessible clinical trial registries such as clinicaltrials.gov.

Investigator-initiated Studies

In the case of investigator-initiated studies, where research is initiated, designed, and conducted by external investigators and institutions, Abbott has less control but still uses reasonable effort to promote disclosure of the study results in a timely and reasonable manner.

Abbott also has additional requirements in place to ensure the safe and appropriate conduct of scientific research.

These checks and balances help to ensure our scientific research activities comply with the laws, regulations, and standards that have been put in place to protect the interests of the people who use and recommend our products.

Abbott is committed to ensuring objectivity in research, protecting research participants, and guaranteeing timely and transparent disclosure of study results.

Laws and regulations governing why we support research

It is illegal to make research payments or provide other items of value in order to improperly induce or reward investigators and HCPs to use or recommend the company’s products. It is also illegal to conduct scientific research as a “disguised” means of promoting unapproved uses of Abbott products.

Laws and Regulations governing how we conduct research

In most trials, government agencies and regulatory authorities specify requirements for nearly every aspect of the research process.

Abbott’s Internal Requirements

Abbott’s internal requirements include the following:

• Research must fill a legitimate need.
• Investigators and sites must be selected based on relevant criteria.
• Compensation paid to investigators or sites must be reasonable and based on fair market value for the country where the research is conducted.
• Study results must be reported in a timely, objective, accurate, and complete manner.
• Scientific research must be conducted in a safe and appropriate manner.

In scientific research, the roles and responsibilities of medical and research personnel differ from those of their sales, marketing, and other non-scientific colleagues.

In this section, we will look at some simple things each of us can do in order to ensure Abbott’s research activities always remain focused on the legitimate advancement of science.

Activity: Dialogue

| Senior Sales Representative

I work in sales, what are some of the key things I need to keep in mind?

For sales, marketing and other functions not responsible for conducting or managing research, here are three important things to remember.

Leave scientific research activities to the research-related functions.

Sales, marketing, and similar non-research functions may provide input on strategic priorities for scientific research, but may not direct, control, or unduly influence decisions relating to research activities.

Limit your input into investigator or site selection to what is permitted in your policies or procedures.

Never lobby research colleagues on behalf of particular investigators or sites. And never demand that a site or investigator be included in a study.

Finally, always refer scientific research questions to an appropriate research representative or resource in your division. This includes:

• Requests for support of IIS/ISS
• Requests from investigators or sites to participate in Abbott Sponsored Studies
• Questions about research involving unapproved products or unapproved uses of approved products

Activity: Dialogue

| Senior R&D Manager

I work in R&D. What are the important things I need to do in order to remain compliant?

If you are part of Abbott’s scientific, medical, or research team responsible for initiating, designing, and/or managing company-sponsored clinical trials and research studies, here is what you need to do.

Always ensure that the trial or study fills a legitimate scientific need and has a clear goal of advancing clinical or scientific understanding.

For example, if you are reviewing a proposed IIS, ensure that

• There is a need for the research,
• The study has clear scientific value, and
• The study can be conducted in accordance with applicable requirements.

Only select investigators and sites for research based on objective criteria relevant to the research itself.

Make sure that all payments for research reflect fair market value.

Ensure that payments are only made for actual research performed, and always based on fair market value for the services being performed.

Always ensure the appropriate and timely reporting of meaningful study results in an objective, accurate, and complete manner as required by Abbott policies and procedures.

Regardless of outcome, never suppress or prohibit the publication of study results.

Be fully transparent regarding involvement in the research and publication process.

Always ensure that Abbott’s involvement (including your own personal involvement) is disclosed in accordance with applicable requirements (e.g., the Abbott Publication Policy).

Always respect the independent nature of IIS research by following applicable requirements regarding Abbott involvement. That means:

• Not taking responsibility for design of the protocol;
• Not helping to conduct or supervise research; and
• Not taking responsibility for data analysis or manuscript development.

If you are unsure or have any questions about your role and responsibilities in respect to scientific research, it is usually best to speak to your manager first. Your manager knows you and your work environment, and is closest to the issues.

The Office of Ethics and Compliance (OEC) and Legal are also resources that can help you analyze the situation and brainstorm alternatives.

If you have concerns about the research practices of a colleague or third-party partner, talk to the OEC or Legal, or voice your concerns via the OEC Helpline at speakup.abbott.com.

(The OEC Helpline is available 24 hours a day 7 days a week and allows you to submit concerns online or by calling an operator who speaks your language.)

In scientific research, the roles and responsibilities of medical and research personnel differ from those of their sales, marketing, and other non-scientific colleagues.

Sales, marketing, and other similar functions

For sales, marketing and other functions not responsible for conducting or managing research, here are three important things to remember:

• Leave scientific research activities to the research-related functions.
• Limit your input into investigator or site selection to what is permitted in your policies or procedures.
• Always refer scientific research questions to an appropriate research representative or resource in your division.

Research and Scientific Functions

If you are part of Abbott’s scientific, medical, or research team responsible for initiating, designing, and/or managing company-sponsored clinical trials and research studies, here is what you need to do:

• Always ensure that the trial or study fills a legitimate scientific need and has a clear goal of advancing clinical or scientific understanding.
• Only select investigators and sites for research based on objective criteria relevant to the research itself.
• Make sure that all payments for research reflect fair market value.
• Always ensure the appropriate and timely reporting of meaningful study results in an objective, accurate, and complete manner as required by Abbott policies and procedures.
• Be fully transparent regarding involvement in the research and publication process.
• Always respect the independent nature of IIS research by following applicable requirements regarding Abbott involvement.

Where to go for support

If you are unsure or have any questions about your role and responsibilities in respect to scientific research, it is usually best to speak to your manager first. If you have concerns about the research practices of a colleague or third-party partner, talk to the OEC or Legal, or voice your concerns via the OEC Helpline at speakup.abbott.com. (The OEC Helpline is available 24 hours a day 7 days a week and allows you to submit concerns online or by calling an operator who speaks your language.)

Manager

If you have questions about scientific research or have concerns about research practices of a colleague or a third-party, the best place to start is with your manager.

Written Standards

• Code of Business Conduct – For our company’s fundamental set of expectations of every employee, consult our Code of Business Conduct.
• Global Policy Portal – For our corporate policies and procedures applicable companywide, visit the Global Policy Portal.

Office of Ethics and Compliance (OEC)

• OEC Website – Refer to the OEC website for answers to a variety of compliance questions, including questions about Abbott’s support of scientific research. Our company’s global and country-specific OEC policies and procedures can also be accessed from the website.
• OEC Contacts – You are encouraged to contact the OEC at any time with any ethics and compliance questions, or to discuss concerns about possible violations of our written standards, laws, or regulations:
• Corporate OEC – Call 1-224-667-5210 or email oec@abbott.com with any questions related to ethics and compliance at Abbott.
• Divisional or Country OEC – Your divisional or country OEC representative can provide additional guidance on divisional or country-specific OEC policies, procedures, and guidelines.
• OEC Helpline – Visit our multilingual OEC Helpline at speakup.abbott.com to voice your concerns about a potential violation of our company’s values and standards of conduct. The OEC Helpline is available 24 hours a day 7 days a week and allows you to submit concerns online or by calling an operator who speaks your language.
• iComply – Visit iComply to access compliance-related applications and resources geared towards interactions with Health Care Professionals and Health Care Organizations.

Legal Division

If you have questions about laws and regulations that govern scientific research, the Legal Division can assist you.

Vendor Credentialing

Many hospitals are now requesting specific documentation that indicates a company representative is qualified to gain access to the Health Care Organization. If you receive such a request, go to hcir.oneabbott.com for information and guidance.

Quick Reference Cards

Click here to review summaries of each section of this course.

Course Transcript

Click here for a full transcript of the course.

Activity: Introduction

The Knowledge Check consists of 10 questions. You must score 80% or higher to successfully complete this course.

When you are ready, click the Knowledge Check button to begin.

Question 1: Scenario

You should talk to the OEC or Legal if you have concerns about the:

Question 1: Options

[1] Research practices of a colleague.

[2] Involvement of sales and marketing personnel in ISS activities.

[3] Research activities of third-party partners.

[4] All of the above.

Question 1: Feedback

If you have concerns about the research practices of a colleague or third-party partner, talk to the OEC or Legal, or voice your concerns via the OEC Helpline at speakup.abbott.com.

For more information about the correct answer, see Section 4.3, Where to Go for Support.

Question 2: Scenario

Abbott selects investigators and sites to perform research based on criteria such as:

Question 2: Options

[1] Qualifications and expertise.

[2] Ability to gain or improve access to customers.

[3] Both 1 and 2.

Question 2: Feedback

Abbott’s selection decisions are never based on marketing objectives, such as the desire to gain or improve access to particular customers or to reward customers for the value or volume of their business. Abbott selects investigators and sites based only on criteria relevant to the research itself.

For more information about the correct answer, see Section 3.2, Laws, Regulations, and Standards.

Question 3: Scenario

Abbott ensures that all research proposals are developed, reviewed, and/or approved by relevant scientific or medical personnel in order to confirm that the research:

Question 3: Options

[1] Follows appropriate clinical or scientific practices.

[2] Has a clear hypothesis or end point.

[3] Has the legitimate goal of advancing clinical or scientific understanding.

[4] All of the above.

Question 3: Feedback

Abbott’s scientific or medical personnel review and confirm that all research fills a legitimate scientific need or interest and has a clear and legitimate goal of advancing clinical or scientific understanding. For example, research is assessed to confirm it follows appropriate clinical or scientific practice and has a clear hypothesis or end point.

For more information about the correct answer, see Section 3.3, Abbott’s Internal Requirements.

Question 4: Scenario

Studies that have the objective of introducing a new product or therapy to physicians:

Question 4: Options

[1] Are permitted for new indications of already approved products.

[2] Can be conducted only in markets where there is a lot of competition between companies trying to sell similar products.

[3] Could be considered illegal if the payment is intended to reward or induce investigators to use or recommend a particular product.

Question 4: Feedback

Studies, where the intended objective is to introduce a new product or therapy to physicians, spur sales of the product, or reward physicians for using a product – rather than test a scientific hypothesis or collect data to fill a legitimate need – are often called “seeding trials” or “marketing trials.” Such trials could be considered illegal, if the payment is intended to reward or induce investigators to use or recommend a particular product.

For more information about the correct answer, see 3.2, Laws, Regulations, and Standards.

Question 5: Scenario

Sales, marketing, and other similar functions may only respond to a scientific research question if it is unsolicited.

Question 5: Options

[1] True.

[2] False.

Question 5: Feedback

Sales, marketing, and other similar functions should refer all scientific research questions to an appropriate research representative or resource in their division.

For more information about the correct answer, see Section 4.2, What to Do – Non-Scientific Functions.

Question 6: Scenario

Scientific and medical personnel involved in providing support for an Investigator-Initiated Study may provide assistance in protocol design and manuscript development.

Question 6: Options

[1] True.

[2] False.

Question 6: Feedback

Scientific, medical, or research teams involved in providing support for Investigator-Initiated Studies/Investigator-Sponsored Studies must always respect the independent nature of the research by following applicable requirements regarding Abbott involvement.

That means:

• Not taking responsibility for design of the protocol;
• Not helping to conduct or supervise research; and
• Not taking responsibility for data analysis or manuscript development.

For more information about the correct answer, see Section 4.3, What to Do – Research and Scientific Functions.

Question 7: Scenario

Sales and marketing personnel may:

Question 7: Options

[1] Provide input into investigator or site selection as permitted by applicable policies and procedures.

[2] Lobby research colleagues on behalf of investigators.

[3] Demand that a site or investigator be included in a study.

[4] All of the above.

Question 7: Feedback

Sales and marketing personnel may provide input into investigator or site selection as allowed by applicable policies or procedures. However, they may never lobby research colleagues on behalf of particular investigators or sites, or demand that a site or investigator be included in a study.

For more information about the correct answer, see Section 4.2, What to Do – Non-Scientific Functions.

Question 8: Scenario

Abbott is solely responsible for the conduct of:

Question 8: Options

[1] Company-sponsored trials.

[2] Investigator-Initiated trials.

[3] Both 1 and 2.

Question 8: Feedback

Abbott is only responsible for the conduct of company-sponsored trials. While we may in some cases choose to provide funding and/or other support for Investigator-Initiated Studies, we are not the study sponsor and are not responsible for conduct of the study.

For more information about the correct answer, see Section 2.3, The Types of Research We Support.

Question 9: Scenario

Compensation paid to investigators or sites must be based on fair market value for the country where:

Question 9: Options

[1] The protocol is designed.

[2] The research is conducted.

[3] The trial is managed.

Question 9: Feedback

Compensation paid to investigators or sites must be based on fair market value for the country where the research is conducted.

For more information about the correct answer, see Section 3.3, Abbott’s Internal Requirements.

Question 10: Scenario

Compensation paid to an investigator may be tied to the outcome of an Investigator-Initiated Study.

Question 10: Options

[1] True.

[2] False.

Question 10: Feedback

Under no circumstances can compensation ever be tied to the outcomes of a study.

For more information about the correct answer, see Section 3.3, Abbott’s Internal Requirements.

All questions remain unanswered

Activity: Overall Feedback

No results are available, as you have not completed the Knowledge Check.

Congratulations! You have successfully passed the Knowledge Check and completed the course.

Please review your results below by clicking on each question.

Once you are done, you must click the EXIT [X] icon in the course title bar before closing your browser window or browser tab.

Sorry, you did not pass the Knowledge Check. Take a few minutes to review your results below by clicking on each question.

When you are done, click the Retake Knowledge Check button.

Introduction

Welcome

Objectives

Tutorial

Advancing Science

Overview

Why We Conduct Research

The Types of Research We Support

Advancing Science: Quick Reference

Scientific Integrity

Overview

Laws, Regulations, and Standards

Abbott’s Internal Requirements

Scientific Integrity: Quick Reference

Playing Your Part

Overview

What to Do – Non-Scientific Functions

What to Do – Research and Scientific Functions

Where to Go for Support

Playing Your Part: Quick Reference

Resources

Where to Get Help

Reference Material

Knowledge Check

Introduction

Knowledge Check

Question 1

Question 2

Question 3

Question 4

Question 5

Question 6

Question 7

Question 8

Question 9

Question 10

Feedback

The Course cannot contact the LMS. Click 'OK' to continue and review the course. Note, Course Certification may not be available. Click 'Cancel' to exit

All questions remain unanswered

Questions

Question

not answered

That's correct!

That's not correct!

Feedback:

Scientific Research Overview

Knowledge Check

Submit

Retake Knowledge Check

Course Description: Scientific research helps us produce products that are not only safe and effective, but also easier to use, more cost effective, and more reliable. The aim of this course is to explain Abbott’s commitment to safeguarding the integrity of scientific research, and to provide practical advice on how to conduct and support research not only in the right way, but also for the right reasons.

Table of Contents

Where to Get Help

Reference Material

Audio

Exit

Close